l.osei
TL2 · Cork
Contributes reviews on supplier material. Based in Cork.
Joined 25 February 2025 · last posted 9d
86Posts here
0Topics
0Solutions
238Likes received
266Likes given
16Badges
131Days visited
1.2kPosts read
Recent activity
Full stream-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #11 · Compounds › Tirzepatide · 19 Jul 2026 · 5 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Blinding yourself: practical methods and their limits Replied, post #42 · Research Methods › N-of-1 designs · 13 Jul 2026 · 12 likes I read post #41 twice before replying, because I had assumed the opposite. Trying to state the blinding yourself position in a way that someone who disagrees would…
-
What I would want from a home test that does not exist yet Replied, post #33 · Analytics › Home & field testing · 10 Jul 2026 · 0 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
-
Seven-day rolling means and why weekly readings mislead Replied, post #6 · Outcomes › Progress reports · 10 Jul 2026 · 0 likes Confirming post #5 from a second method, which matters more than confirming it from a second person. The best progress reports here read as records rather than as…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #50 · Compounds › Retatrutide · 10 Jul 2026 · 0 likes On analysis: a chromatographic purity figure for an investigational compound is harder to interpret than for a well-characterised one, because there is no reference…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #32 · Evidence › Journal club · 7 Jul 2026 · 0 likes This follows post #29 rather than contradicting it. An observation about SUSTAIN 6 that I cannot explain and am posting anyway, on the principle that unexplained…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #97 · Safety › Contraindications · 3 Jul 2026 · 33 likes Answering the question post #93 raises rather than the one it answers. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction…
-
Tracking a shortage from primary sources rather than rumour Replied, post #82 · Access › Shortages · 3 Jul 2026 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. Worth checking against a second source before it gets…
-
Follow-up: Signs of dehydration worth acting on Replied, post #12 · Safety › Adverse events · 3 Jul 2026 · 0 likes The reason Signs of dehydration worth acting keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #39 · Analytics › Home & field testing · 23 Jun 2026 · 1 like Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #21 · Outcomes › Body composition · 18 Jun 2026 · 0 likes Post #19 and I disagree about the size of the effect, not about the direction. Bone mineral density changes with substantial weight loss are measurable and slow, and…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #24 · Analytics › COA interpretation · 7 Jun 2026 · 30 likes Reconciling a label claim has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.